Instil Bio (TIL) Competitors $30.32 +1.32 (+4.55%) Closing price 09/4/2025 04:00 PM EasternExtended Trading$32.02 +1.70 (+5.61%) As of 05:05 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock TIL vs. PROK, TBPH, IMTX, ABUS, GHRS, KALV, KURA, BCAX, RLAY, and KROSShould you be buying Instil Bio stock or one of its competitors? The main competitors of Instil Bio include ProKidney (PROK), Theravance Biopharma (TBPH), Immatics (IMTX), Arbutus Biopharma (ABUS), GH Research (GHRS), KalVista Pharmaceuticals (KALV), Kura Oncology (KURA), Bicara Therapeutics (BCAX), Relay Therapeutics (RLAY), and Keros Therapeutics (KROS). These companies are all part of the "pharmaceutical products" industry. Instil Bio vs. Its Competitors ProKidney Theravance Biopharma Immatics Arbutus Biopharma GH Research KalVista Pharmaceuticals Kura Oncology Bicara Therapeutics Relay Therapeutics Keros Therapeutics ProKidney (NASDAQ:PROK) and Instil Bio (NASDAQ:TIL) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their institutional ownership, risk, dividends, profitability, analyst recommendations, media sentiment, earnings and valuation. Which has preferable valuation and earnings, PROK or TIL? ProKidney has higher revenue and earnings than Instil Bio. ProKidney is trading at a lower price-to-earnings ratio than Instil Bio, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioProKidney$80K8,460.55-$61.19M-$0.57-4.04Instil BioN/AN/A-$74.14M-$12.92-2.35 Is PROK or TIL more profitable? ProKidney's return on equity of 0.00% beat Instil Bio's return on equity.Company Net Margins Return on Equity Return on Assets ProKidneyN/A N/A -17.11% Instil Bio N/A -54.32%-33.65% Which has more risk & volatility, PROK or TIL? ProKidney has a beta of 1.74, suggesting that its stock price is 74% more volatile than the S&P 500. Comparatively, Instil Bio has a beta of 2.16, suggesting that its stock price is 116% more volatile than the S&P 500. Does the media refer more to PROK or TIL? In the previous week, ProKidney had 4 more articles in the media than Instil Bio. MarketBeat recorded 4 mentions for ProKidney and 0 mentions for Instil Bio. ProKidney's average media sentiment score of 0.67 beat Instil Bio's score of 0.00 indicating that ProKidney is being referred to more favorably in the media. Company Overall Sentiment ProKidney Positive Instil Bio Neutral Do analysts recommend PROK or TIL? ProKidney currently has a consensus price target of $6.25, indicating a potential upside of 171.74%. Instil Bio has a consensus price target of $119.00, indicating a potential upside of 292.48%. Given Instil Bio's stronger consensus rating and higher probable upside, analysts clearly believe Instil Bio is more favorable than ProKidney.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score ProKidney 1 Sell rating(s) 2 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.33Instil Bio 0 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 1 Strong Buy rating(s) 3.00 Do insiders and institutionals have more ownership in PROK or TIL? 51.6% of ProKidney shares are owned by institutional investors. Comparatively, 60.6% of Instil Bio shares are owned by institutional investors. 41.5% of ProKidney shares are owned by company insiders. Comparatively, 47.2% of Instil Bio shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. SummaryProKidney and Instil Bio tied by winning 7 of the 14 factors compared between the two stocks. Get Instil Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for TIL and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding TIL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TIL vs. The Competition Export to ExcelMetricInstil BioMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$195.77M$3.13B$5.76B$9.85BDividend YieldN/A2.28%6.67%4.51%P/E Ratio-2.3520.8975.7126.43Price / SalesN/A458.96548.17119.09Price / CashN/A44.5237.0558.92Price / Book1.179.9311.296.06Net Income-$74.14M-$53.38M$3.29B$266.28M7 Day Performance12.30%0.63%0.18%-0.33%1 Month Performance12.34%6.31%6.30%3.43%1 Year Performance114.28%11.63%56.91%23.10% Instil Bio Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TILInstil Bio3.0109 of 5 stars$30.32+4.6%$119.00+292.5%+105.7%$195.77MN/A-2.35410PROKProKidney3.3972 of 5 stars$2.35-2.5%$6.25+166.0%+5.5%$709.22M$80K-4.123TBPHTheravance Biopharma3.6537 of 5 stars$13.80-0.8%$21.33+54.6%+74.8%$700.53M$64.38M57.50110Positive NewsIMTXImmatics2.4227 of 5 stars$5.23-8.1%$14.67+180.4%-49.1%$691.62M$130.13M-8.05260Positive NewsABUSArbutus Biopharma2.5974 of 5 stars$3.50-2.5%$5.50+57.1%-2.0%$688.20M$6.17M-12.0790News CoveragePositive NewsGHRSGH Research2.436 of 5 stars$13.18+0.8%$32.00+142.8%+65.9%$680.53MN/A-17.8110News CoverageKALVKalVista Pharmaceuticals4.0501 of 5 stars$12.99-3.1%$26.29+102.4%+17.6%$675.06MN/A-3.52100News CoverageKURAKura Oncology3.8371 of 5 stars$7.65flat$24.10+215.0%-59.0%$664M$53.88M-3.38130News CoveragePositive NewsAnalyst ForecastBCAXBicara Therapeutics2.5936 of 5 stars$11.32-4.4%$32.25+184.9%N/A$646.03MN/A-3.5732Positive NewsRLAYRelay Therapeutics2.4032 of 5 stars$3.51-4.9%$17.25+391.5%-37.0%$636.20M$8.36M-1.80330News CoverageAnalyst ForecastGap UpKROSKeros Therapeutics3.2305 of 5 stars$14.76-5.1%$30.00+103.3%-70.6%$631.97M$232.84M47.61100News CoveragePositive News Related Companies and Tools Related Companies PROK Competitors TBPH Competitors IMTX Competitors ABUS Competitors GHRS Competitors KALV Competitors KURA Competitors BCAX Competitors RLAY Competitors KROS Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TIL) was last updated on 9/5/2025 by MarketBeat.com Staff From Our Partners“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredHow “Trump’s New Dollar” Could Impact Your WealthPresident Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...Brownstone Research | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredWhat's the Best Way to Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredOne tiny company just cracked Google’s $19B problemFor decades, this “AI metal” was trapped in labs, too slow and expensive to ever reach mass production. The...True Market Insiders | SponsoredWarren Buffett Issues Cryptic Warning on U.S. DollarImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Instil Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Instil Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TIL Stock Alerts